Health
Loveworld Medical Centre hosts international symposium on future of nuclear medicine
Loveworld Medical Centre is set to host an international symposium on Radionuclide Therapy and Oncology which aims to shape the future of nuclear medicine around the globe.
The event which is scheduled for 6th of July 2024 at the Loveworld Medical Centre, located at 51/53 Kudirat Abiola Way, Oregun, Lagos, is themed, “Evolving role of nuclear medicine and personalized, precision medicine.”
Leading minds and practitioners in the field of nuclear medicine and oncology from around the globe are expected to be part of the symposium.
Distinguished Speakers expected at the symposium include: Dr. Masha Maharaj – Nuclear Medicine Physician, Loveworld Medical Centre; Secretary, World Association of Radiopharmaceutical & Molecular Therapy (WARMTH); Prof. Knut Liepe – Head of Department, Nuclear Medicine, Klinikum Frankfurt (Oder);Prof. Mboyo-Di-Tamba Willy Vangu – Chief Specialist and Head of Nuclear Medicine, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital.
READ ALSO: LoveWorld’s Rhapsody of Realities now most translated publication in the World
Others are: Prof. Tamara Geliashvili – Head, Radionuclide Therapy Department, Research Institute of Clinical and Experimental Radiology, N.N. Blokhin NMRCO; Prof. Andrey A. Stanjevskii – Professor, Nuclear Medicine Department, Almazov National Medical Centre; Dr. Foluso Arewa – Chief Consultant Nuclear Medicine Physician, Radiation and Clinical Oncologist, National Hospital, Abuja, Nigeria and Mr. Adamu Abdul – Nuclear Regulatory Authority (NNRA) Coordinator, South West Zonal Office, Lagos, Nigeria among many other leading minds.
Symposium chairman, Dr. Emeka Eze, Clinical Director at LWC and Chairman of ISRT, said the symposium aims to explore the latest advancements and innovations in nuclear medicine, particularly focusing on the growing impact of personalized and precision medicine in treating cancer and other health conditions.
He said attendees would have the opportunity to engage with international experts, gain insights into groundbreaking research, and explore collaborative opportunities.
Chief Operating Officer, Loveworld Medical Centre, Dr. Anthony Oseghale, revealed that given the dynamic landscape of radionuclide therapy and oncology, the event marks a significant milestone for medical professionals, researchers, and policy makers dedicated to advancing healthcare outcomes through the power of nuclear medicine.
Executive Chairman of Loveworld Medical Centre and Chief Host, Dr. Deola Phillips, encouraged practitioners and other concerned stakeholders to participate in the event as it promises to set new standards in medical symposiums and fuel the progression of precision medicine.
